ImmunityBio replaces auditor EY with Deloitte for fiscal year 2025

ImmunityBio, Inc.

Audit committee dismissed Ernst & Young as independent auditor on March 13, 2025; no disagreements or reportable events.
Deloitte & Touche appointed as new independent auditor for fiscal year ending Dec 31, 2025, subject to client acceptance.
EY provided a letter (Exhibit 16.1) agreeing with the company's disclosures in this 8-K.
Company did not consult Deloitte on accounting principles during the two most recent fiscal years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.